The Blood Processing Devices and Consumables Market was valued at USD 48.3 billion in 2023 and is expected to reach USD 89.41 billion by 2032, growing at a CAGR of 7.11% over the forecast period of 2024-2032. This report identifies the prevalence and incidence of blood disorders, propelling the demand for sophisticated blood-processing solutions to aid in transfusion and therapy procedures. This study investigates blood donation and transfusion patterns in regions shaped by awareness drives, availability of donors, and healthcare infrastructures. Furthermore, the report analyzes healthcare expenditure on blood processing, as differences in government, commercial, private, and out-of-pocket spending determine market trends. The report explores new technologies and innovations in blood processing, such as automated separation methods and AI-based quality control systems, improving efficiency and safety. Regional regulatory patterns and compliance norms are important influencers of product approvals and manufacturing protocols to maintain safety and efficacy in blood handling processes.
The U.S. Blood Processing Devices and Consumables Market valued at USD 14.23 billion in 2023 and is expected to hit USD 23.82 billion by 2032 at a CAGR of 5.91% over the forecast period of 2024-2032. In the US, rising blood component demand, expanding investments in advanced processing technology, and the stringent FDA rules are fueling market growth, while voluntary blood donation campaigns continue to support supply stability.
Drivers
The rising prevalence of blood-related disorders and increasing demand for blood transfusions.
Diseases like anemia, hemophilia, leukemia, and trauma cases have immensely raised the demand for blood-processing equipment. The WHO states that more than 118.5 million blood donations are received worldwide annually, making it necessary to have advanced blood separation and pathogen reduction technologies. Moreover, the growing number of surgeries, organ transplants, and cancer therapies is driving the demand for automated blood processing equipment. The increasing trend towards automated blood management systems is enhancing efficiency and minimizing human errors, further driving market growth. Advances in technology, like next-generation apheresis systems, AI-driven blood analyzers, and disposable blood processing kits, are making the process safer and more accurate. Increasing investments in blood banks and healthcare infrastructure, coupled with government support initiatives towards blood donation awareness, further drive market growth. For instance, the U.S. Department of Health & Human Services' "National Blood Supply" program works towards reinforcing blood banking infrastructures, driving market expansion. Furthermore, mounting anxiety regarding the spread of infectious diseases through blood transfusions has pushed the demand for pathogen reduction technologies at a faster pace, providing safer blood supply chains and propelling the demand for quality blood processing equipment.
Restraints
High cost of blood processing devices and consumables, limiting their adoption, especially in low-income and developing regions.
High-tech blood processing equipment, including automated apheresis systems and pathogen reduction technologies, is priced between USD 30,000 and USD 100,000, which makes them economically infeasible for most healthcare institutions. The lack of skilled personnel in blood banking and transfusion medicine also holds back market expansion as these systems need to be used with expert training. Regulatory complexities are also a significant challenge, with complex approval processes of organizations like the FDA, EMA, and WHO, which postpone product launches. Further, limited reimbursement policies for blood transfusions and processing procedures impose economic burdens on hospitals and diagnostic laboratories, inhibiting their investment in sophisticated equipment. The threat of blood contamination and waste associated with ineffective storage and processing technologies continues to pose a challenge, necessitating higher compliance standards. In addition, the dependency on voluntary donations that tend to change with demographic and seasonal factors influences the supply of blood products, restricting the requirement for processing tools. All these aspects cumulatively limit the scalability and reach of blood processing technologies, particularly in resource-scarce healthcare environments.
Opportunities
The growing focus on automation and AI-driven blood processing solutions presents significant opportunities for market expansion.
Automated blood processing equipment minimizes human errors, improving efficiency and enhancing the safety of blood products overall. The use of artificial intelligence-based hematology analyzers and intelligent blood storage systems is optimizing processes, accelerating tasks, and reducing costs. Moreover, growing needs for individualized medicine and cell therapy are pushing innovation in blood component separation and stem cell processing, with new revenue opportunities. The growth of point-of-care blood processing technology, especially in acute and remote care areas, represents significant growth prospects. Businesses are making investments in portable and compact blood processing tools for the acceleration of blood tests and transfusions away from their usual hospital surroundings. Additionally, collaborations among blood banks, biotech companies, and healthcare operators are improving development and research activities for next-generation blood processing devices. The growing demand for sustainable and environmentally friendly blood processing consumables, including biodegradable blood bags and non-toxic anticoagulants, represents another emerging trend. In addition, government-driven initiatives for universal blood screening and safety regulations will be expected to propel the usage of sophisticated processing technologies, assuring long-term market expansion.
Challenges
One of the biggest challenges in the market is the global shortage of blood donations, which directly impacts the demand for blood-processing devices.
Even with WHO efforts to promote voluntary blood donation, several regions continue to have severe shortages, resulting in unmet transfusion requirements. Moreover, the market has logistical and supply chain issues in ensuring the cold chain and appropriate storage conditions for blood products, particularly in low-resource environments. The threat of transfusion-transmissible infections (TTIs), including HIV, hepatitis, and bacterial contamination, is a serious issue, requiring rigorous blood screening practices. Yet, the deployment of these screening procedures involves heavy investments in infrastructure and compliance, which is a strain on small healthcare facilities. The other significant challenge is the standardization of blood processing methods across regions since regulatory guidelines are extremely diverse across countries. This diversity makes product approvals and market entry strategies for device manufacturers complicated. Additionally, the growing cybersecurity risks within automated blood banking systems threaten data breaches, affecting patient safety and business efficiency. The resolution of these issues will involve joint efforts by regulatory authorities, healthcare organizations, and technology innovators to implement safer, more efficient blood-processing technology globally.
By Product
Devices dominated the share of the blood processing devices and consumables market, with 56.8% of all revenue in 2023. The leadership of devices is fueled by the extensive use of automated blood processing technologies such as centrifuges, apheresis devices, and leukoreduction filters. The rising need for effective blood separation, pathogen reduction, and component storage solutions has driven market growth. Furthermore, blood banks and hospitals are making investments in sophisticated equipment for blood processing to increase the safety of transfusions and reduce wastage.
Consumables are estimated to exhibit the highest growth during the forecast period as a result of increasing demand for disposable blood bags, reagents, collection tubes, and filtration kits. The growing rates of blood donations and transfusions, combined with stringent infection control policies, are contributing to the increasing demand for single-use consumables. Furthermore, the cost-effectiveness and simplicity of the replacement of consumables in blood banks and healthcare centers also bolster market growth.
By End Use
Hospitals and clinics dominated the market in 2023, with the largest revenue share, owing to the significant number of blood transfusions, surgeries, and emergency procedures that necessitate blood components. Advanced blood processing infrastructure existing within the country, combined with more patient admissions for chronic diseases and trauma cases, accounted for the dominance of the segment. Moreover, hospitals are the central point of care for critical conditions such as cancer, anemia, and hemophilia, further reaffirming their market position.
Diagnostic laboratories are forecasted to increase at the most rapid pace as a result of increasing demand for blood-based diagnostics, growing incidence of infectious diseases, and hematology testing advancements. The use of automated blood analyzers, molecular diagnostics, and point-of-care testing is broadening laboratory services, which contributes to higher market penetration. In addition, the drive towards preventive care and early disease diagnosis is energizing demand for blood processing consumables and devices used in the diagnostic environment.
North America led the blood processing devices and consumables market with revenue share of around 39% in 2023, fueled by sophisticated healthcare facilities, superior blood donation rates, and enormous investments in blood safety devices. The country with the most leading position is the U.S., aided by national programs like the American Red Cross and AABB (Association for the Advancement of Blood & Biotherapies) that have strong adherence to blood processing standards. Furthermore, the region is aided by the presence of leading industry players and high penetration levels of automated blood processing systems. Europe ranks second due to stringent regulatory structures, established blood banking infrastructures, and growing demand for pathogen-reduced blood components.
Asia-Pacific is the most rapidly expanding region, propelled by escalating investments in healthcare, increasing awareness about blood donation, and the growing prevalence of chronic conditions. China, India, and Japan are experiencing high demand for blood processing consumables because of growing hospital infrastructure and a rise in the number of surgeries and transfusions. The Asia-Pacific market for blood processing is likely to experience double-digit growth, driven by government-sponsored blood donation campaigns and advances in blood storage and separation methods. Additionally, the increasing incidence of blood disorders like thalassemia and hemophilia is also driving market growth in the region.
bioMérieux SA – BACT/ALERT Blood Culture System, VIDAS Immunoassay Blood Screening
Abbott – ARCHITECT i1000SR & i2000SR Immunoassay Analyzers, Alinity s System for Blood & Plasma Screening
Bio-Rad Laboratories, Inc. – IH-500 & IH-1000 Blood Typing Analyzers, D-10 Hemoglobin Testing System
BD (Becton, Dickinson and Company) – BD Vacutainer Blood Collection Tubes, BD BACTEC Blood Culture System
F. Hoffmann-La Roche Ltd – cobas 6800/8800 Blood Screening Systems, Accu-Chek Blood Glucose Monitoring
Danaher Corporation – Beckman Coulter DxH 900 Hematology Analyzer, Leica Biosystems Pathology Solutions
Immucor, Inc. – Echo Lumena Blood Typing System, NEO Iris Blood Bank Analyzer
ThermoGenesis Holdings, Inc. – AXP II Automated Cell Processing System, BioArchive Smart Cryopreservation System
Grifols, S.A. – Procleix Panther Blood Screening System, Erytra Automated Blood Typing System
Terumo Corporation – Spectra Optia Apheresis System, Terumo Blood Bags & Blood Collection Sets
Haemonetics Corporation – MCS+ Apheresis System, NexSys PCS Plasma Collection System
Macopharma – Leucoflex Leukoreduction Filters, Macopress Smart Blood Component Separator
In Feb 2025, Tasso, Inc. introduced its next-generation dried blood spot (DBS) sample collection technology, featuring the Tile-T20 dried whole blood cartridge integrated with the Tasso Mini device. This innovation enhances the accuracy and convenience of DBS collection, catering to clinical trials and sports anti-doping testing.
In March 2024, the FDA granted 510(k) clearance to RedDrop Dx for its RedDrop One blood collection device. This innovative device enables the collection of larger blood volumes with enhanced reliability, improving efficiency in blood sampling and diagnostics.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 48.3 billion |
| Market Size by 2032 | USD 89.41 billion |
| CAGR | CAGR of 7.11% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product [Devices (Cell Processors, Hematocrit Centrifuges, Blood Bank Refrigerators, Blood Bank Freezers, Grouping Analyzers, Warmers), Consumables (Blood Co-agulation Reagents, Blood Grouping Reagents, Hematology Reagents, Blood Administration Sets, Sedimentation Tubes, Blood Bags, Blood Collection Tubes, Blood Collection Needles, Blood Lancets, Blood Filters, Vials, Slide Stainer, Test Tube Racks, Slides)] • By End Use [Hospitals and Clinics, Diagnostic Laboratories, Others] |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | bioMérieux SA, Abbott, Bio-Rad Laboratories, Inc., BD (Becton, Dickinson and Company), F. Hoffmann-La Roche Ltd, Danaher Corporation, Immucor, Inc., ThermoGenesis Holdings, Inc., Grifols, S.A., Terumo Corporation, Haemonetics Corporation, Macopharma. |
Ans: The Blood Processing Devices and Consumables Market is projected to grow at a CAGR of 7.11% during the forecast period.
Ans: By 2032, the Blood Processing Devices and Consumables Market is expected to reach USD 89.41 billion, up from USD 48.3 billion in 2023.
Ans: The rising prevalence of blood-related disorders and increasing demand for blood transfusions.
Ans: The market faces significant restraints due to the high cost of blood processing devices and consumables, limiting their adoption, especially in low-income and developing regions.
Ans: North America is the dominant region in the Blood Processing Devices and Consumables Market.
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence of Blood-Related Disorders (2023)
5.2 Blood Donation and Transfusion Trends (2023), by Region
5.3 Healthcare Spending on Blood Processing, by Region (Government, Commercial, Private, Out-of-Pocket), 2023
5.4 Emerging Technologies and Innovations in Blood Processing
5.5 Regional Regulatory Trends and Compliance Standards
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Service Benchmarking
6.3.1 Service specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Service launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Blood Processing Devices and Consumables Market Segmentation, by Product
7.1 Chapter Overview
7.2 Devices
7.2.1 Devices Market Trends Analysis (2020-2032)
7.2.2 Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3 Cell Processors
7.2.3.1 Cell Processors Market Trends Analysis (2020-2032)
7.2.3.2 Cell Processors Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4 Hematocrit Centrifuges
7.2.4.1 Hematocrit Centrifuges Market Trends Analysis (2020-2032)
7.2.4.2 Hematocrit Centrifuges Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.5 Blood Bank Refrigerators
7.2.5.1 Blood Bank Refrigerators Market Trends Analysis (2020-2032)
7.2.5.2 Blood Bank Refrigerators Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.6 Blood Bank Freezers
7.2.6.1 Blood Bank Freezer Market Trends Analysis (2020-2032)
7.2.6.2 Blood Bank Freezer Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.7 Grouping Analyzers
7.2.7.1 Grouping Analyzers Market Trends Analysis (2020-2032)
7.2.7.2 Grouping Analyzers Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.8 Warmers
7.2.8.1 Warmers Market Trends Analysis (2020-2032)
7.2.8.2 Warmers Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Consumables
7.3.1 Consumables Market Trends Analysis (2020-2032)
7.3.2 Consumables Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.3 Blood Coagulation Reagents
7.3.3.1 Blood Coagulation Reagents Market Trends Analysis (2020-2032)
7.3.3.2 Blood Coagulation Reagents Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.4 Blood Grouping Reagents
7.3.4.1 Blood Grouping Reagents Market Trends Analysis (2020-2032)
7.3.4.2 Blood Grouping Reagents Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.5 Hematology Reagents
7.3.5.1 Hematology Reagents Market Trends Analysis (2020-2032)
7.3.5.2 Hematology Reagents Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.6 Blood Administration Sets
7.3.6.1 Blood Administration Sets Market Trends Analysis (2020-2032)
7.3.6.2 Blood Administration Sets Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.7 Sedimentation Tubes
7.3.7.1 Sedimentation Tubes Market Trends Analysis (2020-2032)
7.3.7.2 Sedimentation Tubes Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.8 Blood Bags
7.3.8.1 Blood Bags Market Trends Analysis (2020-2032)
7.3.8.2 Blood Bags Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.9 Blood Collection Tubes
7.3.9.1 Blood Collection Tubes Market Trends Analysis (2020-2032)
7.3.9.2 Blood Collection Tubes Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.10 Blood Collection Needles
7.3.10.1 Blood Collection Needles Market Trends Analysis (2020-2032)
7.3.10.2 Blood Collection Needles Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.11 Blood Lancets
7.3.11.1 Blood Lancets Market Trends Analysis (2020-2032)
7.3.11.2 Blood Lancets Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.12 Blood Filters
7.3.12.1 Blood Filters Market Trends Analysis (2020-2032)
7.3.12.2 Blood Filters Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.13 Vials
7.3.13.1 Vials Market Trends Analysis (2020-2032)
7.3.13.2 Vials Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.14 Slide Stainer
7.3.14.1 Slide Stainer Market Trends Analysis (2020-2032)
7.3.14.2 Slide Stainer Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.15 Test Tube Racks
7.3.15.1 Test Tube Racks Market Trends Analysis (2020-2032)
7.3.15.2 Test Tube Racks Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.16 Slides
7.3.16.1 Slides Market Trends Analysis (2020-2032)
7.3.16.2 Slides Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Blood Processing Devices and Consumables Market Segmentation, by End Use
8.1 Chapter Overview
8.2 Hospitals and Clinics
8.2.1 Hospitals and Clinics Market Trends Analysis (2020-2032)
8.2.2 Hospitals and Clinics Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Diagnostic Laboratories
8.3.1 Diagnostic Laboratories Market Trends Analysis (2020-2032)
8.3.2 Diagnostic Laboratories Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Others
8.4.1 Others Market Trends Analysis (2020-2032)
8.4.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Blood Processing Devices and Consumables Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.2.3 North America Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.4 North America Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.2.5 USA
9.2.5.1 USA Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.5.2 USA Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.2.6 Canada
9.2.6.1 Canada Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.6.2 Canada Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.2.7 Mexico
9.2.7.1 Mexico Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.7.2 Mexico Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe Blood Processing Devices and Consumables Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.1.3 Eastern Europe Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.4 Eastern Europe Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.1.5 Poland
9.3.1.5.1 Poland Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.5.2 Poland Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.1.6 Romania
9.3.1.6.1 Romania Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.6.2 Romania Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.1.7 Hungary
9.3.1.7.1 Hungary Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.7.2 Hungary Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.1.8 Turkey
9.3.1.8.1 Turkey Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.8.2 Turkey Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.9.2 Rest of Eastern Europe Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe Blood Processing Devices and Consumables Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.2.3 Western Europe Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.4 Western Europe Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.2.5 Germany
9.3.2.5.1 Germany Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.5.2 Germany Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.2.6 France
9.3.2.6.1 France Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.6.2 France Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.2.7 UK
9.3.2.7.1 UK Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.7.2 UK Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.2.8 Italy
9.3.2.8.1 Italy Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.8.2 Italy Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.2.9 Spain
9.3.2.9.1 Spain Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.9.2 Spain Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.10.2 Netherlands Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.2.11 Switzerland
9.3.2.11.1 Switzerland Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.11.2 Switzerland Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.2.12 Austria
9.3.2.12.1 Austria Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.12.2 Austria Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.2.13 Rest of Western Europe
9.3.2.13.1 Rest of Western Europe Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.13.2 Rest of Western Europe Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Blood Processing Devices and Consumables Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.4.3 Asia Pacific Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.4 Asia Pacific Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.4.5 China
9.4.5.1 China Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.5.2 China Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.4.6 India
9.4.5.1 India Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.5.2 India Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.4.5 Japan
9.4.5.1 Japan Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.5.2 Japan Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.4.6 South Korea
9.4.6.1 South Korea Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.6.2 South Korea Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.4.7 Vietnam
9.4.7.1 Vietnam Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.7.2 Vietnam Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.4.8 Singapore
9.4.8.1 Singapore Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.8.2 Singapore Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.4.9 Australia
9.4.9.1 Australia Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.9.2 Australia Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.4.10 Rest of Asia Pacific
9.4.10.1 Rest of Asia Pacific Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.10.2 Rest of Asia Pacific Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East Blood Processing Devices and Consumables Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.1.3 Middle East Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.4 Middle East Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.5.1.5 UAE
9.5.1.5.1 UAE Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.5.2 UAE Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.5.1.6 Egypt
9.5.1.6.1 Egypt Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.6.2 Egypt Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.5.1.7 Saudi Arabia
9.5.1.7.1 Saudi Arabia Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.7.2 Saudi Arabia Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.5.1.8 Qatar
9.5.1.8.1 Qatar Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.8.2 Qatar Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.9.2 Rest of Middle East Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa Blood Processing Devices and Consumables Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.2.3 Africa Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.2.4 Africa Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.5.2.5 South Africa
9.5.2.5.1 South Africa Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.2.5.2 South Africa Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.5.2.6 Nigeria
9.5.2.6.1 Nigeria Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.2.6.2 Nigeria Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Blood Processing Devices and Consumables Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.6.3 Latin America Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.4 Latin America Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.6.5 Brazil
9.6.5.1 Brazil Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.5.2 Brazil Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.6.6 Argentina
9.6.6.1 Argentina Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.6.2 Argentina Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.6.7 Colombia
9.6.7.1 Colombia Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.7.2 Colombia Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.6.8 Rest of Latin America
9.6.8.1 Rest of Latin America Blood Processing Devices and Consumables Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.8.2 Rest of Latin America Blood Processing Devices and Consumables Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10. Company Profiles
10.1 bioMérieux SA
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Products/ Services Offered
10.1.4 SWOT Analysis
10.2 Abbott
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Products/ Services Offered
10.2.4 SWOT Analysis
10.3 Bio-Rad Laboratories, Inc.
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Products/ Services Offered
10.3.4 SWOT Analysis
10.4 BD (Becton, Dickinson and Company)
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Products/ Services Offered
10.4.4 SWOT Analysis
10.5 F. Hoffmann-La Roche Ltd
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Products/ Services Offered
10.5.4 SWOT Analysis
10.6 Danaher Corporation
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Products/ Services Offered
10.6.4 SWOT Analysis
10.7 Immucor, Inc.
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Products/ Services Offered
10.7.4 SWOT Analysis
10.8 ThermoGenesis Holdings, Inc.
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Products/ Services Offered
10.8.4 SWOT Analysis
10.9 Grifols, S.A.
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
10.10 Terumo Corporation
10.10.1 Company Overview
10.10.2 Financial
10.10.3 Products/ Services Offered
10.10.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Product
Devices
Cell Processors
Hematocrit Centrifuges
Blood Bank Refrigerators
Blood Bank Freezers
Grouping Analyzers
Warmers
Consumables
Blood Co-agulation Reagents
Blood Grouping Reagents
Hematology Reagents
Blood Administration Sets
Sedimentation Tubes
Blood Bags
Blood Collection Tubes
Blood Collection Needles
Blood Lancets
Blood Filters
Vials
Slide Stainer
Test Tube Racks
Slides
By End Use
Hospitals and Clinics
Diagnostic Laboratories
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The Healthcare Multi-Cloud Management Market was valued at USD 0.984 billion in 2023 and is expected to reach USD 12.91 billion by 2032, growing at a CAGR of 30.93% over the forecast period of 2024-2032.
The Wheelchair Market size was estimated at USD 5.04 billion in 2023 and is expected to reach USD 9.58 billion by 2032 at a CAGR of 7.4% from 2024 to 2032.
The Wearable Cardiac Devices Market size was USD 3.72 billion in 2023, projected to reach USD 25.71 billion by 2032, at a CAGR of 24.0% from 2024-2032.
The Cardiac Rhythm Management Devices Market was valued at USD 18.51 billion in 2023, projected to reach USD 32.35 billion by 2032, growing at a CAGR of 6.40%.
The Medical Aesthetics market size was USD 19.28 billion in 2023 and is expected to reach USD 56.41 billion by 2032 and grow at a CAGR of 12.67% over the forecast period of 2024-2032.
The Weight Loss Drugs Market Size was valued at USD 1.92 Billion in 2023 and is expected to reach USD 50.26 Billion by 2032, growing at a CAGR of 43.73% over the forecast period of 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
